News
ANIK
15.14
+0.26%
0.04
Weekly Report: what happened at ANIK last week (0622-0626)?
Weekly Report · 5h ago
Anika Shareholders Approve Directors and Expanded Incentive Plans
TipRanks · 5d ago
Weekly Report: what happened at ANIK last week (0615-0619)?
Weekly Report · 06/22 09:48
Weekly Report: what happened at ANIK last week (0608-0612)?
Weekly Report · 06/15 09:49
Weekly Report: what happened at ANIK last week (0601-0605)?
Weekly Report · 06/08 09:46
ANIKA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 06/05 21:00
Weekly Report: what happened at ANIK last week (0525-0529)?
Weekly Report · 06/01 09:49
Weekly Report: what happened at ANIK last week (0518-0522)?
Weekly Report · 05/25 09:50
Anika Therapeutics Signals Momentum Amid Regulatory Risks
TipRanks · 05/20 00:43
Weekly Report: what happened at ANIK last week (0511-0515)?
Weekly Report · 05/18 09:50
Weekly Report: what happened at ANIK last week (0504-0508)?
Weekly Report · 05/11 09:48
Anika Therapeutics Director John B. Henneman III acquires 5,000 shares for $73,319.50
PUBT · 05/04 12:35
Weekly Report: what happened at ANIK last week (0427-0501)?
Weekly Report · 05/04 09:47
Friday 5/1 Insider Buying Report: GEHC, ANIK
NASDAQ · 05/01 17:39
Top Executive Makes Bold Insider Move at Anika Therapeutics
TipRanks · 05/01 02:03
Anika CEO Stephen Griffin buys $149,881 common shares
PUBT · 04/30 22:03
TELA BIO INC - CHAIRMAN DOUG EVANS, KURT AZARBARZIN, VINCE BURGESS, FEDERICA O’BRIEN TO DEPART BOARD
Reuters · 04/30 20:43
Anika Therapeutics announces annual shareholder meeting webcast
PUBT · 04/30 19:48
Anika Therapeutics publishes 2025 annual report on Form 10-K
PUBT · 04/30 19:48
Bullish On Anika Therapeutics's Pullback As Integrity Scales
Seeking Alpha · 04/30 15:21
More
Webull provides a variety of real-time ANIK stock news. You can receive the latest news about Anika Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About ANIK
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.